Although data regarding blood transfusion in early and late coagulopathy in traumatic brain injury are limited, an increasing number of investigations focus on the administration of recombinant factor VII as primary therapy for isolated TBI-related coagulopathy [29-31]. Here, F7 is linked to brain injury.